de la Rubia Ortí, J.E.; Platero, J.L.; Benlloch, M.; Franco-Martinez, L.; Tvarijonaviciute, A.; Escribá-Alepuz, J.; Sancho-Castillo, S.
Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study. Biomolecules 2021, 11, 617.
https://doi.org/10.3390/biom11050617
AMA Style
de la Rubia Ortí JE, Platero JL, Benlloch M, Franco-Martinez L, Tvarijonaviciute A, Escribá-Alepuz J, Sancho-Castillo S.
Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study. Biomolecules. 2021; 11(5):617.
https://doi.org/10.3390/biom11050617
Chicago/Turabian Style
de la Rubia Ortí, Jose Enrique, Jose Luis Platero, María Benlloch, Lorena Franco-Martinez, Asta Tvarijonaviciute, Jesús Escribá-Alepuz, and Sandra Sancho-Castillo.
2021. "Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study" Biomolecules 11, no. 5: 617.
https://doi.org/10.3390/biom11050617
APA Style
de la Rubia Ortí, J. E., Platero, J. L., Benlloch, M., Franco-Martinez, L., Tvarijonaviciute, A., Escribá-Alepuz, J., & Sancho-Castillo, S.
(2021). Role of Haptoglobin as a Marker of Muscular Improvement in Patients with Multiple Sclerosis after Administration of Epigallocatechin Gallate and Increase of Beta-Hydroxybutyrate in the Blood: A Pilot Study. Biomolecules, 11(5), 617.
https://doi.org/10.3390/biom11050617
